The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism

A 43-year-old African American with end-stage renal disease (ESRD) associated with membranous nephropathy and a previously failed renal transplant had received cinacalcet to treat his secondary hyperparathyroidism. Serum calcium and phosphorus levels remained within normal limits, and serum parathyr...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalpey, Zain, Nehs, Matthew A., ElBardissi, Andrew W., Semel, Marcus, Tullius, Stefan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421548/
https://www.ncbi.nlm.nih.gov/pubmed/25949409
http://dx.doi.org/10.1093/ndtplus/sfp120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421548/
https://www.ncbi.nlm.nih.gov/pubmed/25949409
http://dx.doi.org/10.1093/ndtplus/sfp120

Ejemplares similares